AVN-944

CAT:
804-HY-13560-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
AVN-944 - image 1

AVN-944

  • Description :

    AVN-944 (VX-944) is an orally active, potent, selective, noncompetitive and specific inhibitor of IMPDH (inosine monophosphate dehydrogenase) . AVN-944 is an essential rate-limiting enzyme in de novo guanine nucleotide synthesis. AVN-944 is also an inhibitor of arenavirus RNA synthesis, and blocks arenavirus infection. AVN-944 has broad anti-cancer activities, and can be used for multiple myeloma (MM) and acute myeloid leukemia (AML) research[1][2][3].
  • Product Name Alternative :

    VX-944
  • UNSPSC :

    12352005
  • Hazard Statement :

    H302, H315, H319, H335
  • Target :

    Apoptosis; Arenavirus; Bcl-2 Family; Caspase; DNA/RNA Synthesis
  • Type :

    Reference compound
  • Related Pathways :

    Anti-infection; Apoptosis; Cell Cycle/DNA Damage
  • Applications :

    Cancer-programmed cell death
  • Field of Research :

    Cancer; Infection
  • Assay Protocol :

    https://www.medchemexpress.com/AVN-944.html
  • Purity :

    99.89
  • Solubility :

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles :

    O=C(O[C@@H](CC#N)CC)N[C@H](C1=CC=CC(NC(NC2=CC=C(C3=CN=CO3)C(OC)=C2)=O)=C1)C
  • Molecular Formula :

    C25H27N5O5
  • Molecular Weight :

    477.51
  • Precautions :

    H302, H315, H319, H335
  • References & Citations :

    [1]Zimmermann AG, et al. Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation. Prog Nucleic Acid Res Mol Biol. 1998;61:181-209.|[2]Huang M, et al. Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption. Leuk Res. 2008 Jan;32 (1) :131-41.|[3]Floryk D, et al. Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells. Int J Cancer. 2008 Nov 15;123 (10) :2294-302.
  • Shipping Conditions :

    Room Temperature
  • Storage Conditions :

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category :

    Reference compound1
  • Clinical Information :

    Phase 2
  • Isoform :

    Bak; Bax; Caspase 3; Caspase 8; Caspase 9
  • CAS Number :

    [297730-17-7]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide